Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 27.50
0.00 (0.01%)
Oct 7, 2026, 5:15 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 38.11 million as of October 15, 2026. It is the 30,229th most valuable company in the world and the 670th biggest in the United Kingdom. Its market cap has increased by 17.45% in one year.
Market Cap
38.11M
Enterprise Value
35.62M
Revenue
n/a
Global Rank
Country Rank
#670 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 38.11M, an increase of 338.31%. That is a compound annual growth rate of 7.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 38.11M | 84.00% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 91.44M |
| 4basebio | 79.09M |
| Faron Pharmaceuticals Oy | 74.35M |
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 50.39M |
| Hemogenyx Pharmaceuticals | 41.75M |
| Arecor Therapeutics | 37.49M |
| ImmuPharma | 23.14M |